Tovoli F.; Guerra P.; Iavarone M.; Veronese L.; Renzulli M.; De Lorenzo S.; Benevento F.; Brandi G.; Stefanini F.; Piscaglia F., Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis, «LIVER CANCER», 2020, 11, pp. 1 - 12 [articolo]Open Access
Piscaglia F.; Marcelli E., The expanding potential of functional liver imaging: From research tools to clinical practice in oncology and internal medicine, «EUROPEAN JOURNAL OF INTERNAL MEDICINE», 2020, 79, pp. 23 - 24 [replica/breve intervento]
Cucchetti, A.; Evans, D.; Casadei-Gardini, A.; Piscaglia, F.; Maroni, L.; Odaldi, F.; Ercolani, G., The perceived ability of gastroenterologists, hepatologists and surgeons can bias medical decision making, «INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH», 2020, 17, Article number: 1058, pp. 1058 - 1058 [articolo]Open Access
Francesco Caputo,Vincenzo Dadduzio,Francesco Tovoli,Giulia Bertolini,Giuseppe Cabibbo,Krisida Cerma,Caterina Vivaldi,Luca Faloppi,Mario Domenico Rizzato,Fabio Piscaglia,Ciro Celsa,Lorenzo Fornaro,Giorgia Marisi,Fabio Conti,Nicola Silvestris,Marianna Silletta,Sara Lonardi,Alessandro Granito,Caterina Stornello,Valentina Massa,Giorgio Astara,Sabina Delcuratolo,Stefano Cascinu,Mario Scartozzi,Andrea Casadei-Gardini, The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib, «PLOS ONE», 2020, 15, Article number: e0232449, pp. 1 - 13 [articolo]Open Access
Kono Y.; Sirlin C.B.; Fetzer D.T.; Kim T.K.; Rodgers S.K.; Piscaglia F.; Lyshchik A.; Dietrich C.F.; Wilson S.R., Time to clarify common misconceptions about the liver imaging reporting and data system for contrast-enhanced US, «RADIOLOGY», 2020, 295, pp. 245 - 247 [replica/breve intervento]
Leoni S.; Sansone V.; De Lorenzo S.; Ielasi L.; Tovoli F.; Renzulli M.; Golfieri R.; Spinelli D.; Piscaglia F., Treatment of combined hepatocellular and cholangiocarcinoma, «CANCERS», 2020, 12, Article number: 794, pp. 794 - 809 [articolo]Open Access
Thiele, M.; Hugger, M. B.; Kim, Y.; Rautou, P. -E.; Elkrief, L.; Jansen, C.; Verlinden, W.; Allegretti, G.; Israelsen, M.; Stefanescu, H.; Piscaglia, F.; Garcia-Pagan, J. C.; Franque, S.; Berzigotti, A.; Castera, L.; Jeong, W. K.; Trebicka, J.; Krag, A., 2D shear wave liver elastography by Aixplorer to detect portal hypertension in cirrhosis: An individual patient data meta-analysis, «LIVER INTERNATIONAL», 2020, 40, pp. 1435 - 1446 [articolo]
Pettinari I.; Vukotic R.; Stefanescu H.; Pecorelli A.; Morelli M.; Grigoras C.; Sparchez Z.; Andreone P.; Piscaglia F.; Badia L.; Cappelli A.; Cescon M.; Conti F.; Cucchetti A.; Galaverni C.; Golfieri R.; Granito A.; Mosconi C.; Renzulli M.; Tame M.; Verucchi G.; Vitale G.; Bolondi L., Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis, «THE AMERICAN JOURNAL OF GASTROENTEROLOGY», 2019, 114, pp. 258 - 266 [articolo]
Lisotti, Andrea; Piscaglia, Fabio; Fusaroli, Pietro, Contrast-enhanced harmonic endoscopic ultrasound-guided ethanol injection for a small hepatocellular carcinoma, «ENDOSCOPY», 2019, 51, pp. 317 - 318 [articolo]
Evans T.R.J.; Kudo M.; Finn R.S.; Han K.-H.; Cheng A.-L.; Ikeda M.; Kraljevic S.; Ren M.; Dutcus C.E.; Piscaglia F.; Sung M.W., Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma (British Journal of Cancer, (2019), 121, 3, (218-221), 10.1038/s41416-019-0506-6), «BRITISH JOURNAL OF CANCER», 2019, 121, pp. 625 - 625 [articolo]
Mulazzani, Lorenzo; Cantisani, Vito; Piscaglia, Fabio*, Different techniques for ultrasound liver elastography, «JOURNAL OF HEPATOLOGY», 2019, 70, pp. 545 - 547 [articolo]
Serio I.; Napoli L.; Leoni S.; Piscaglia F., Direct antiviral agents for HCV infection and hepatocellular carcinoma: Facts and FADs, «TRANSLATIONAL CANCER RESEARCH», 2019, 8, pp. S223 - S232 [articolo]
Sagrini, E.; Iavarone, M.; Stefanini, F.; Tovoli, F.; Vavassori, S.; Maggioni, M.; Renzulli, M.; Salvatore, V.; Stefanescu, H.; Colombo, M.; Bolondi, L.; Piscaglia, F., Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma, «UNITED EUROPEAN GASTROENTEROLOGY JOURNAL», 2019, 7, pp. 69 - 77 [articolo]
Tovoli F.; Casadei-Gardini A.; Benevento F.; Piscaglia F., Immunotherapy for hepatocellular carcinoma: A review of potential new drugs based on ongoing clinical studies as of 2019, «DIGESTIVE AND LIVER DISEASE», 2019, 51, pp. 1067 - 1073 [articolo]
Ielasi, L.; Tovoli, F.; Piscaglia, F., Lenvatinib mesylate to treat hepatocellular carcinoma, «DRUGS OF TODAY», 2019, 55, pp. 305 - 313 [articolo]
